169 related articles for article (PubMed ID: 32141297)
21. Conserved polar residues in transmembrane domains V, VI, and VII of free fatty acid receptor 2 and free fatty acid receptor 3 are required for the binding and function of short chain fatty acids.
Stoddart LA; Smith NJ; Jenkins L; Brown AJ; Milligan G
J Biol Chem; 2008 Nov; 283(47):32913-24. PubMed ID: 18801738
[TBL] [Abstract][Full Text] [Related]
22. Discovery and characterization of 2-(cyclopropanesulfonamido)-N-(2-ethoxyphenyl)benzamide, ML382: a potent and selective positive allosteric modulator of MrgX1.
Wen W; Wang Y; Li Z; Tseng PY; McManus OB; Wu M; Li M; Lindsley CW; Dong X; Hopkins CR
ChemMedChem; 2015 Jan; 10(1):57-61. PubMed ID: 25209672
[TBL] [Abstract][Full Text] [Related]
23. Structure-Activity Relationship Explorations and Discovery of a Potent Antagonist for the Free Fatty Acid Receptor 2.
Højgaard Hansen A; Christensen HB; Pandey SK; Sergeev E; Valentini A; Dunlop J; Dedeo D; Fratta S; Hudson BD; Milligan G; Ulven T; Rexen Ulven E
ChemMedChem; 2021 Nov; 16(21):3326-3341. PubMed ID: 34288488
[TBL] [Abstract][Full Text] [Related]
24. Extracellular loop 2 of the free fatty acid receptor 2 mediates allosterism of a phenylacetamide ago-allosteric modulator.
Smith NJ; Ward RJ; Stoddart LA; Hudson BD; Kostenis E; Ulven T; Morris JC; Tränkle C; Tikhonova IG; Adams DR; Milligan G
Mol Pharmacol; 2011 Jul; 80(1):163-73. PubMed ID: 21498659
[TBL] [Abstract][Full Text] [Related]
25. Identification and pharmacological characterization of multiple allosteric binding sites on the free fatty acid 1 receptor.
Lin DC; Guo Q; Luo J; Zhang J; Nguyen K; Chen M; Tran T; Dransfield PJ; Brown SP; Houze J; Vimolratana M; Jiao XY; Wang Y; Birdsall NJ; Swaminath G
Mol Pharmacol; 2012 Nov; 82(5):843-59. PubMed ID: 22859723
[TBL] [Abstract][Full Text] [Related]
26. Endochin optimization: structure-activity and structure-property relationship studies of 3-substituted 2-methyl-4(1H)-quinolones with antimalarial activity.
Cross RM; Monastyrskyi A; Mutka TS; Burrows JN; Kyle DE; Manetsch R
J Med Chem; 2010 Oct; 53(19):7076-94. PubMed ID: 20828199
[TBL] [Abstract][Full Text] [Related]
27. Integrated In Silico Fragment-Based Drug Design: Case Study with Allosteric Modulators on Metabotropic Glutamate Receptor 5.
Bian Y; Feng Z; Yang P; Xie XQ
AAPS J; 2017 Jul; 19(4):1235-1248. PubMed ID: 28560482
[TBL] [Abstract][Full Text] [Related]
28. Design, Synthesis, and Characterization of Ogerin-Based Positive Allosteric Modulators for G Protein-Coupled Receptor 68 (GPR68).
Yu X; Huang XP; Kenakin TP; Slocum ST; Chen X; Martini ML; Liu J; Jin J
J Med Chem; 2019 Aug; 62(16):7557-7574. PubMed ID: 31298539
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of 3,4-dihydroquinolin-2(1H)-one derivatives with anticonvulsant activity and their binding to the GABA
Wang S; Liu H; Lei K; Li G; Li J; Wei Y; Wang X; Liu R
Bioorg Chem; 2020 Oct; 103():104182. PubMed ID: 32890992
[TBL] [Abstract][Full Text] [Related]
30. Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor.
Miao Y; Goldfeld DA; Moo EV; Sexton PM; Christopoulos A; McCammon JA; Valant C
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5675-84. PubMed ID: 27601651
[TBL] [Abstract][Full Text] [Related]
31. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
Grundmann M; Bender E; Schamberger J; Eitner F
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578942
[TBL] [Abstract][Full Text] [Related]
32. Orally bioavailable 6-chloro-7-methoxy-4(1H)-quinolones efficacious against multiple stages of Plasmodium.
Cross RM; Flanigan DL; Monastyrskyi A; LaCrue AN; Sáenz FE; Maignan JR; Mutka TS; White KL; Shackleford DM; Bathurst I; Fronczek FR; Wojtas L; Guida WC; Charman SA; Burrows JN; Kyle DE; Manetsch R
J Med Chem; 2014 Nov; 57(21):8860-79. PubMed ID: 25148516
[TBL] [Abstract][Full Text] [Related]
33. Detailed structure-activity relationship of indolecarboxamides as H4 receptor ligands.
Engelhardt H; de Esch IJ; Kuhn D; Smits RA; Zuiderveld OP; Dobler J; Mayer M; Lips S; Arnhof H; Scharn D; Haaksma EE; Leurs R
Eur J Med Chem; 2012 Aug; 54():660-8. PubMed ID: 22749391
[TBL] [Abstract][Full Text] [Related]
34. Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).
Pidathala C; Amewu R; Pacorel B; Nixon GL; Gibbons P; Hong WD; Leung SC; Berry NG; Sharma R; Stocks PA; Srivastava A; Shone AE; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Hill A; Fisher NE; Warman AJ; Biagini GA; Ward SA; O'Neill PM
J Med Chem; 2012 Mar; 55(5):1831-43. PubMed ID: 22364416
[TBL] [Abstract][Full Text] [Related]
35. Novel free fatty acid receptor 1 (GPR40) agonists based on 1,3,4-thiadiazole-2-carboxamide scaffold.
Krasavin M; Lukin A; Zhurilo N; Kovalenko A; Zahanich I; Zozulya S; Moore D; Tikhonova IG
Bioorg Med Chem; 2016 Jul; 24(13):2954-2963. PubMed ID: 27229618
[TBL] [Abstract][Full Text] [Related]
36. Free fatty acid receptor 1 (GPR40) agonists containing spirocyclic periphery inspired by LY2881835.
Krasavin M; Lukin A; Bagnyukova D; Zhurilo N; Zahanich I; Zozulya S; Ihalainen J; Forsberg MM; Lehtonen M; Rautio J; Moore D; Tikhonova IG
Bioorg Med Chem; 2016 Nov; 24(21):5481-5494. PubMed ID: 27647366
[TBL] [Abstract][Full Text] [Related]
37. In vitro and mouse in vivo characterization of the potent free fatty acid 1 receptor agonist TUG-469.
Urban C; Hamacher A; Partke HJ; Roden M; Schinner S; Christiansen E; Due-Hansen ME; Ulven T; Gohlke H; Kassack MU
Naunyn Schmiedebergs Arch Pharmacol; 2013 Dec; 386(12):1021-30. PubMed ID: 23861168
[TBL] [Abstract][Full Text] [Related]
38. Discovery of 9-Cyclopropylethynyl-2-((
Labéguère F; Dupont S; Alvey L; Soulas F; Newsome G; Tirera A; Quenehen V; Mai TTT; Deprez P; Blanqué R; Oste L; Le Tallec S; De Vos S; Hagers A; Vandevelde A; Nelles L; Vandervoort N; Conrath K; Christophe T; van der Aar E; Wakselman E; Merciris D; Cottereaux C; da Costa C; Saniere L; Clement-Lacroix P; Jenkins L; Milligan G; Fletcher S; Brys R; Gosmini R
J Med Chem; 2020 Nov; 63(22):13526-13545. PubMed ID: 32902984
[TBL] [Abstract][Full Text] [Related]
39. Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41.
Natarajan N; Hori D; Flavahan S; Steppan J; Flavahan NA; Berkowitz DE; Pluznick JL
Physiol Genomics; 2016 Nov; 48(11):826-834. PubMed ID: 27664183
[TBL] [Abstract][Full Text] [Related]
40. Pharmacophore-guided repurposing of fibrates and retinoids as GPR40 allosteric ligands with activity on insulin release.
Cione E; Caroleo MC; Kagechika H; Manetti F
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):377-383. PubMed ID: 33525941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
